<DOC>
	<DOCNO>NCT00084266</DOCNO>
	<brief_summary>To determine linezolid superior vancomycin treatment nosocomial ( acquired hospital ) pneumonia due Methicillin Resistant Staphylococcus Aureus ( MRSA ) adult subject . Subjects enter study proven healthcare-associated methicillin-resistant Staphylococcus aureus pneumonia treat either linezolid vancomycin .</brief_summary>
	<brief_title>Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus ( MRSA )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>Hospitalized male female subject clinically document nosocomial pneumonia proven due methicillinresistant staphylococcus aureus . Chest Xray baseline/screen within 48 hour treatment consistent diagnosis pneumonia . Suitable sputum specimen define less 10 squamous epithelial cell great equal 25 leukocyte culture take invasive technique within 24 hour study entry . Subjects treat previous antibiotic MRSA activity ( linezolid vancomycin ) 48 hour , unless document treatment failure ( 72 hour treatment respond ) . Subjects severe neutropenia ( &lt; 500 cells/mm3 ) Subjects hypersensitivity oxazolidinones vancomycin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Staphylococcal pneumonia</keyword>
	<keyword>Methicillin-resistant staphylococcal pneumonia</keyword>
	<keyword>healthcare-associated pneumonia</keyword>
</DOC>